ScholarIQanswers from OpenAlex & ORCID
Yan Lin
ResearcherPublications, citations & collaboration network
Yan Lin is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Yan Lin have?
ScholarIQindexed works
Yan Lin has 224 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Yan Lin have?
ScholarIQcitation count
Yan Lin has 2,913 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Yan Lin?
ScholarIQh-index
Yan Lin has an h-index of 27 in OpenAlex.
What is the i10-index of Yan Lin?
ScholarIQi10-index
Yan Lin has an i10-index of 78 in OpenAlex.
What is the ORCID of Yan Lin?
ScholarIQorcid
The ORCID for Yan Lin is on the source record.
What is the OpenAlex record for Yan Lin?
ScholarIQopenalex
The OpenAlex for Yan Lin is on the source record.
What are the most-cited papers on Yan Lin?
ScholarIQmost cited works
Clinical Outcomes for Peripartum Cardiomyopathy in North America
Dennis M. McNamara, Uri Elkayam, Rami Alharethi, Julie B. Damp, Eileen Hsich, Gregory A. Ewald, Kalgi Modi, Jeffrey D. Alexis, Gautam Ramani, Marc J. Semigran, Jennifer Haythe, David W. Markham, Josef Marek, John Gorcsan, Wen‐Chi Wu, Yan Lin, Indrani Halder, Jessica Pisarcik, Leslie T. Cooper, James D. Fett
Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke
David Tanné, Richard F. Macko, Yan Lin, Barbara C. Tilley, Steven R. Levine
Magnesium supplementation during cardiopulmonary bypass to prevent junctional ectopic tachycardia after pediatric cardiac surgery: A randomized controlled study
Ana Manrique, Margarita Arroyo, Yan Lin, Samar R. El Khoudary, Erin L. Colvin, Steven Lichtenstein, Constantinos Chrysostomou, Richard A. Orr, Edmund H. Jooste, Peter J. Davis, Peter D. Wearden, Victor O. Morell, Ricardo Muñoz
Antibody-Derived<i>In Vivo</i>Imaging of Tau Pathology
Senthilkumar Krishnaswamy, Yan Lin, Wajitha J. Rajamohamedsait, Hameetha B. Rajamohamedsait, Pavan Krishnamurthy, Einar M. Sigurdsson
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer
Xiaotian Zhang, Jufeng Wang, Gang Wang, Yanqiao Zhang, Qingxia Fan, Chuangxin Lu, Changlu Hu, Meili Sun, Yiye Wan, Sanyuan Sun, Junye Wang, Li Zhang, Yongqian Shu, Jie Luo, Dan Zhu, Zhenwei Shen, Sheng Yao, Qingmei Shi, Jason Yang, Lin Shen, GEMSTONE-303 Investigators, Yanru Xie, Xiaoyan Lin, Jiayi Li, Yunpeng Liu, Ruixing Zhang, Xiao Li, Ping Chen, Xinhui Yang, Zishu Wang, Zhanxiong Luo, Qi Li, Yanrong Gao, Qi Wang, Jianping Xiong, Ting Fu, Yan Lin, Zhong Xie, Yunbo Zhao, Yiping Mou, Tao Zhang, Wangjun Liao, Yinping Sun, Dong Yan, Yanxia Ji, Hongxia Li, Yongquan Shi, Hongming Pan, Yanhong Deng, Yanhua Chen, Juntao Yao, Anji Hou, Xinjun Liang